DK1334105T3 - Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat) - Google Patents

Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)

Info

Publication number
DK1334105T3
DK1334105T3 DK01980805T DK01980805T DK1334105T3 DK 1334105 T3 DK1334105 T3 DK 1334105T3 DK 01980805 T DK01980805 T DK 01980805T DK 01980805 T DK01980805 T DK 01980805T DK 1334105 T3 DK1334105 T3 DK 1334105T3
Authority
DK
Denmark
Prior art keywords
monohydrate
crystalline
preparation
formimidoylthienamycin
imipenem
Prior art date
Application number
DK01980805T
Other languages
Danish (da)
English (en)
Inventor
Yatendra Kumar
Neera Tewari
Ram Chander Aryan
Bishwa Prakash Rai
Seema Ahuja
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097114&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1334105(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of DK1334105T3 publication Critical patent/DK1334105T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01980805T 2000-11-03 2001-11-05 Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat) DK1334105T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN983DE2000 IN191798B (hu) 2000-11-03 2000-11-03

Publications (1)

Publication Number Publication Date
DK1334105T3 true DK1334105T3 (da) 2006-08-14

Family

ID=11097114

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01980805T DK1334105T3 (da) 2000-11-03 2001-11-05 Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)

Country Status (19)

Country Link
US (1) US7078534B2 (hu)
EP (1) EP1334105B1 (hu)
JP (1) JP2004525084A (hu)
KR (1) KR20030059812A (hu)
CN (1) CN100445284C (hu)
AT (1) ATE322495T1 (hu)
AU (1) AU2002212591A1 (hu)
BG (1) BG107852A (hu)
CA (1) CA2427762C (hu)
DE (1) DE60118593D1 (hu)
DK (1) DK1334105T3 (hu)
EA (1) EA006442B1 (hu)
EE (1) EE200300206A (hu)
ES (1) ES2261494T3 (hu)
IN (1) IN191798B (hu)
MX (1) MXPA03003916A (hu)
PT (1) PT1334105E (hu)
WO (1) WO2002036594A1 (hu)
ZA (1) ZA200303338B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK15092003A3 (sk) 2001-05-18 2004-09-08 Ranbaxy Laboratories Limited Spôsob izolácie kryštalického imipenému
US7462712B2 (en) * 2001-05-18 2008-12-09 Ranbaxy Laboratories Limited Process for the preparation of imipenem
NZ529625A (en) * 2001-05-18 2006-02-24 Ranbaxy Lab Ltd Process for the preparation of amorphous cilastatin sodium
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
EA200400682A1 (ru) * 2001-11-16 2004-10-28 Рэнбакси Лабораториз Лимитед Способ получения кристаллического имипенема
US6537985B1 (en) * 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
KR100667373B1 (ko) * 2003-12-09 2007-01-10 주식회사 중외제약 이미페넴의 신규 제조방법
KR100848751B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 이미페넴의 제조방법
KR100848752B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 티에나마이신 용매화합물 및 그의 제조방법
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN111413427A (zh) * 2020-04-08 2020-07-14 苏州和合医学检验有限公司 超滤前处理高效液相色谱测定血浆中亚胺培南含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
JP3048196B2 (ja) 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
ATE150463T1 (de) 1991-10-01 1997-04-15 Procter & Gamble Pharma Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
FI104822B (fi) 1992-09-09 2000-04-14 Sankyo Co Menetelmä karbapeneemi- ja peneemiyhdisteiden valmistamiseksi
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics

Also Published As

Publication number Publication date
MXPA03003916A (es) 2004-01-29
IN191798B (hu) 2004-01-03
EP1334105B1 (en) 2006-04-05
EA200300520A1 (ru) 2003-10-30
CN100445284C (zh) 2008-12-24
KR20030059812A (ko) 2003-07-10
BG107852A (bg) 2004-01-30
AU2002212591A1 (en) 2002-05-15
ATE322495T1 (de) 2006-04-15
EA006442B1 (ru) 2005-12-29
DE60118593D1 (de) 2006-05-18
CN1481384A (zh) 2004-03-10
JP2004525084A (ja) 2004-08-19
US7078534B2 (en) 2006-07-18
ES2261494T3 (es) 2006-11-16
CA2427762A1 (en) 2002-05-10
WO2002036594A1 (en) 2002-05-10
EP1334105A1 (en) 2003-08-13
CA2427762C (en) 2009-10-20
PT1334105E (pt) 2006-08-31
US20040054167A1 (en) 2004-03-18
EE200300206A (et) 2003-10-15
ZA200303338B (en) 2004-03-09

Similar Documents

Publication Publication Date Title
YU5503A (sh) Nesteroidni supresori zapaljenja
ATE318139T1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
DK1334105T3 (da) Fremgangsmåde til fremstilling af krystallinsk N-formimidoylthienamycinmonohydrat (imipenemmonohydrat)
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
ATE381539T1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
WO2003002530A3 (en) Pyrrolidines as dipeptidyl peptidase inhibitors
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
WO2004062613A3 (en) Hiv integrase inhibitors
MY142423A (en) Substituted aminoacetyl pyrrolidine compounds which are dipeptidyl peptidase iv inhibitors, and pharmaceutical compositions containing them
UA81567C2 (en) Heteroaroyl-substituted phenylalanine amides
NO20035603D0 (no) Fluorpyrrolidiner som dipeptidyl peptidase inhibitorer
AU2001249091A1 (en) Novel methods using cholinesterase inhibitors
WO2007031858A3 (en) An improved process for the preparation of beta-lactam antibiotic
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
MXPA05009611A (es) Piperidinas sustituidas como nuevos inhibidores de mdm2-p53.
MXPA05010440A (es) Amidas del acido isoquinolina-5-sulfonico como inhibidores de la akt (proteina quinasa b).
HK1100659A1 (en) Hiv protease inhibiting compounds hiv
EA200200819A1 (ru) Кристаллическая форма ii линезолида
WO2004091504A3 (en) Substituted quinobenzoxazine analogs
BR0307595A (pt) Uso de inibidores de pde5 tal como sildenafil no tratamento de sìndrome de ovário policìstico
TW200719889A (en) Amino acid derivatives
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
TW200643018A (en) Process for the preparation of substituted benzoxazole compounds